Pfizer Inc. (PFE)
Pre-market:
| Previous close | 30.07 |
| Open | 30.05 |
| Bid | 0.00 x 2900 |
| Ask | 29.81 x 4000 |
| Day's range | 29.60 - 30.14 |
| 52-week range | 25.20 - 34.11 |
| Volume | |
| Avg. volume | 31,706,922 |
| Market cap | 169.038B |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.46 |
| Earnings date | 29 Oct 2024 |
| Forward dividend & yield | 1.68 (5.63%) |
| Ex-dividend date | 26 Jul 2024 |
| 1y target est | 33.38 |
Insider MonkeyPfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income
We recently compiled a list of the 7 Best Stocks to Buy for Passive Income. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other good stocks to buy for passive income. With rising costs in today’s world, people are constantly searching for ways to earn additional […]
ZacksNovartis' Kisqali Lowers Risk of Breast Cancer Recurrence by 28%
NVS' breast cancer drug Kisqali reduces the risk of disease recurrence by 28.5% in a broad population of patients suffering from early breast cancer.
Business WirePfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts
NEW YORK, September 17, 2024--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, October 29, 2024. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Third Quarter 2024 Performance Report, to be issued that morning.
